135 related articles for article (PubMed ID: 7123673)
21. Tamoxifen in early breast cancer.
Bryce CJ
Lancet; 1998 Aug; 352(9125):403. PubMed ID: 9717952
[No Abstract] [Full Text] [Related]
22. Endocrine therapy of advanced breast cancer.
Rose C; Mouridsen HT
Acta Oncol; 1988; 27(6A):721-8. PubMed ID: 3064777
[TBL] [Abstract][Full Text] [Related]
23. Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy.
Campbell FC; Blamey RW; Elston CW; Morris AH; Nicholson RI; Griffiths K; Haybittle JL
Lancet; 1981 Dec; 2(8259):1317-9. PubMed ID: 6118718
[TBL] [Abstract][Full Text] [Related]
24. Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management.
Allan SG; Rodger A; Smyth JF; Leonard RC; Chetty U; Forrest AP
Br Med J (Clin Res Ed); 1985 Feb; 290(6465):358. PubMed ID: 3917820
[No Abstract] [Full Text] [Related]
25. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial.
Boccardo F; Rubagotti A; Amoroso D; Sismondi P; Genta F; Nenci I; Piffanelli A; Farris A; Castagnetta L; Traina A
Eur J Cancer; 1992; 28(2-3):673-80. PubMed ID: 1591091
[TBL] [Abstract][Full Text] [Related]
26. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
[TBL] [Abstract][Full Text] [Related]
27. [Results of anti-estrogen therapy in metastatic breast cancer (preliminary results). Part II].
Firusian N; Schmidt CG
Med Welt; 1977 Dec; 28(51-52):2065-7. PubMed ID: 414049
[No Abstract] [Full Text] [Related]
28. [Adjuvant endocrine therapy of breast cancer].
Jonat W; Maass H
ZFA (Stuttgart); 1983 Apr; 59(10):571-4. PubMed ID: 6868762
[No Abstract] [Full Text] [Related]
29. Endocrine treatment of advanced breast cancer.
Maass H; Jonat W
Recent Results Cancer Res; 1980; 71():102-11. PubMed ID: 6988909
[No Abstract] [Full Text] [Related]
30. Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).
Kaufmann M; Jonat W; Abel U
Recent Results Cancer Res; 1989; 115():118-25. PubMed ID: 2696024
[No Abstract] [Full Text] [Related]
31. Effect of antiestrogen therapy on human mammary carcinomas with different estrogen receptor contents.
Westerberg H; Nordenskjold B; Wrange O; Gustafsson JA; Humla S; Theve NO; Silfverswärd C; Granberg PO
Eur J Cancer (1965); 1978 Jun; 14(6):619-22. PubMed ID: 658084
[No Abstract] [Full Text] [Related]
32. Therapeutic effect of tamoxifen related to estrogen receptor level.
Rose C; Thorpe SM; Løber J; Daenfeldt JL; Palshof T; Mouridsen HT
Recent Results Cancer Res; 1980; 71():134-41. PubMed ID: 6988911
[TBL] [Abstract][Full Text] [Related]
33. Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial.
Kurosumi M; Takatsuka Y; Watanabe T; Imoto S; Inaji H; Tsuda H; Akiyama F; Sakamoto G; Ikeda T; Noguchi S
J Cancer Res Clin Oncol; 2008 Jun; 134(6):715-22. PubMed ID: 18075758
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant endocrine therapy of primary operable breast cancer. Report on the Copenhagen breast cancer trials.
Palshof T; Mouridsen HT; Daehnfeldt JL
Eur J Cancer (1965); 1980; Suppl 1():183-7. PubMed ID: 7032931
[No Abstract] [Full Text] [Related]
35. Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
Carlson RW; Henderson IC
Breast Cancer Res Treat; 2003; 80 Suppl 1():S19-26; discussion S27-8. PubMed ID: 14535531
[TBL] [Abstract][Full Text] [Related]
36. [7 years' experience in the determination of hormone receptors in cancer of the breast. Current status and prospectives for the surgeon].
Pietrarota P; Battistoni MG; Caprioli F
Pathologica; 1987; 79(1059-1060):105-8. PubMed ID: 3441400
[No Abstract] [Full Text] [Related]
37. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
Nomura Y; Tashiro H; Hisamatsu K; Toi M
Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
[TBL] [Abstract][Full Text] [Related]
38. Metastatic breast carcinoma with positive estrogen and progesterone receptors in a man with Klinefelter's syndrome.
Ellison HS; Scheuer SA; Eichner ER
South Med J; 1980 Oct; 73(10):1393-6. PubMed ID: 7434059
[TBL] [Abstract][Full Text] [Related]
39. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen.
Gaskell DJ; Hawkins RA; Sangsterl K; Chetty U; Forrest AP
Lancet; 1989 May; 1(8646):1044-6. PubMed ID: 2566000
[TBL] [Abstract][Full Text] [Related]
40. Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast.
Kuerer HM; Buzdar AU; Singletary SE
J Surg Oncol; 2001 Jun; 77(2):139-47. PubMed ID: 11398169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
